Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cashflow Statement

GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,063 Cr₹1,133 Cr₹1,055 Cr₹1,619 Cr₹1,335 Cr
Adjustment ₹212 Cr₹224 Cr₹38 Cr₹-28 Cr₹17 Cr
Changes In working Capital ₹-6.06 Cr₹-53 Cr₹-418 Cr₹-393 Cr₹-436 Cr
Cash Flow after changes in Working Capital ₹1,269 Cr₹1,303 Cr₹675 Cr₹1,197 Cr₹916 Cr
Cash Flow from Operating Activities ₹915 Cr₹997 Cr₹364 Cr₹791 Cr₹605 Cr
Cash Flow from Investing Activities ₹1,705 Cr₹-1,757 Cr₹1,208 Cr₹-1,003 Cr₹-1,524 Cr
Cash Flow from Financing Activities ₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr₹1,238 Cr
Net Cash Inflow / Outflow ₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr₹319 Cr
Opening Cash & Cash Equivalents ₹357 Cr₹1,909 Cr₹319 Cr₹492 Cr₹169 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹13 Cr₹7.72 Cr₹3.00 Cr₹3.31 Cr₹3.58 Cr
Closing Cash & Cash Equivalent ₹2,556 Cr₹357 Cr₹1,909 Cr₹319 Cr₹492 Cr

Compare Cashflow Statement of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,162.7 Cr 7% -5.2% 5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

7%

-5.2%

5%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses